Literature DB >> 29193052

Association Between Migraine and Suicidal Behaviors: A Nationwide Study in the USA.

Lauren E Friedman1, Qiu-Yue Zhong1, Bizu Gelaye1, Michelle A Williams1, B Lee Peterlin2.   

Abstract

BACKGROUND: Recent studies show migraineurs are at an increased risk of developing suicidal behaviors, even after controlling for comorbid depression. However, previous research has not examined the impact of psychiatric mood disorders on suicidal behaviors in migraineurs within a nationally representative sample.
OBJECTIVE: A cross-sectional study was used to investigate the association between migraine and suicidal behaviors and determine whether psychiatric comorbidities modify this association in a nationwide inpatient cohort.
METHODS: We analyzed the Nationwide Inpatient Sample of hospitalizations compiled from USA billing data. Migraine, suicidal behaviors, and psychiatric disorders were identified based on the International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes from hospitalization discharges (2007-2012). Weighted national estimates were used to estimate odds ratios (OR) and 95% confidence intervals (CI).
RESULTS: 156,172,826 hospitalizations were included, of which 1.4% had a migraine diagnosis and 1.6% had a diagnosis of suicidal behavior. Migraineurs had a 2.07-fold increased odds of suicidal behaviors (95%CI: 1.96-2.19) compared with non-migraineurs. We repeated analyses after stratifying by depression, anxiety, or posttraumatic stress disorder (PTSD). Among hospitalizations with depression, migraine was associated with a 20% reduced odds of suicidal behaviors (95%CI: 0.76-0.85). Among hospitalizations without depression, migraine was associated with 2.35-fold increased odds of suicidal behaviors (95%CI: 2.20-2.51). In stratified analyses, we noted that among hospitalizations with anxiety, migraineurs had slightly increased odds of suicidal behaviors (OR: 1.07, 95%CI: 1.02-1.13). Among hospitalizations without anxiety, migraine was associated with a 2.06-fold increased odds of suicidal behaviors (95%CI: 1.94-2.20). Similarly, in analyses stratified by PTSD, migraine was not associated with an increased risk of suicidal behaviors (OR: 1.00, 95%CI: 0.94-1.07) among those with PTSD. However, the odds of suicidal behaviors were increased among hospitalizations without PTSD (OR: 1.95, 95%CI: 1.84-2.08).
CONCLUSION: Chronic conditions that do not affect the current hospitalization may not have been reported. The presence of psychiatric diagnoses influences associations of suicidal behaviors with migraine in a national inpatient sample. Migraineurs with diagnosed comorbid psychiatric disorders may be receiving care that mitigates their risk for suicidal behaviors.
© 2017 American Headache Society.

Entities:  

Keywords:  anxiety; depression; migraine; posttraumatic stress disorder; suicidal behavior

Mesh:

Year:  2017        PMID: 29193052      PMCID: PMC5890952          DOI: 10.1111/head.13235

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  39 in total

Review 1.  The impact of physical pain on suicidal thoughts and behaviors: Meta-analyses.

Authors:  Raffaella Calati; Camelia Laglaoui Bakhiyi; Sylvaine Artero; Mark Ilgen; Philippe Courtet
Journal:  J Psychiatr Res       Date:  2015-09-11       Impact factor: 4.791

2.  Is migraine a risk factor for pediatric stroke?

Authors:  Amy A Gelfand; Heather J Fullerton; Alice Jacobson; Stephen Sidney; Peter J Goadsby; Tobias Kurth; Alice Pressman
Journal:  Cephalalgia       Date:  2015-03-09       Impact factor: 6.292

Review 3.  Sex-related differences in migraine.

Authors:  Cinzia Finocchi; Laura Strada
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

4.  Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).

Authors:  Michael Stokes; Werner J Becker; Richard B Lipton; Sean D Sullivan; Teresa K Wilcox; Leandra Wells; Aubrey Manack; Irina Proskorovsky; Jonathan Gladstone; Dawn C Buse; Sepideh F Varon; Peter J Goadsby; Andrew M Blumenfeld
Journal:  Headache       Date:  2011 Jul-Aug       Impact factor: 5.887

5.  Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management.

Authors:  Michel Lantéri-Minet; Françoise Radat; Marie-Hélène Chautard; Christian Lucas
Journal:  Pain       Date:  2005-11-14       Impact factor: 6.961

Review 6.  The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies.

Authors:  Rebecca C Burch; Stephen Loder; Elizabeth Loder; Todd A Smitherman
Journal:  Headache       Date:  2015-01       Impact factor: 5.887

7.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

8.  Migraine, suicidal ideation, and suicide attempts.

Authors:  N Breslau
Journal:  Neurology       Date:  1992-02       Impact factor: 9.910

9.  Depression and risk of transformation of episodic to chronic migraine.

Authors:  Sait Ashina; Daniel Serrano; Richard B Lipton; Morris Maizels; Aubrey N Manack; Catherine C Turkel; Michael L Reed; Dawn C Buse
Journal:  J Headache Pain       Date:  2012-09-25       Impact factor: 7.277

10.  Suicidal ideation in a population-based sample of adolescents: implications for family medicine practice.

Authors:  Esme Fuller-Thomson; Gail P Hamelin; Stephen J R Granger
Journal:  ISRN Family Med       Date:  2013-01-30
View more
  3 in total

1.  The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients.

Authors:  Marta Kowalska; Magdalena Kapelusiak-Pielok; Teresa Grzelak; Ewa Wypasek; Wojciech Kozubski; Jolanta Dorszewska
Journal:  Front Mol Neurosci       Date:  2018-06-05       Impact factor: 5.639

2.  A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine.

Authors:  Angelo Camporeale; David Kudrow; Ryan Sides; Shufang Wang; Annelies Van Dycke; Katherine J Selzler; Virginia L Stauffer
Journal:  BMC Neurol       Date:  2018-11-09       Impact factor: 2.474

Review 3.  Comorbidities of primary headache disorders: a literature review with meta-analysis.

Authors:  Valeria Caponnetto; Manuela Deodato; Paolo Martelletti; Alberto Raggi; Micaela Robotti; Maria Koutsokera; Valeria Pozzilli; Cristina Galati; Giovanna Nocera; Eleonora De Matteis; Gioacchino De Vanna; Emanuela Fellini; Gleni Halili; Daniele Martinelli; Gabriele Nalli; Serena Serratore; Irene Tramacere
Journal:  J Headache Pain       Date:  2021-07-14       Impact factor: 7.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.